About the Study

Eosinophilic gastritis (EG) and eosinophilic gastroenteritis (EGE) are rare chronic diseases that affects an estimate 40 in 100,000 people in the United States. That number is most likely underestimated due to not having a standard diagnostic criteria nor having enough awareness about the disease. Many times when people have GI tract issues (such as EG and EGE), they suffer from common symptoms like abdominal pain, nausea, vomiting, diarrhea, and dysphagia. Current treatment options include diet restriction and corticosteroids which are often ineffective and inappropriate for long term use.

Baptist Health is currently seeking individuals between the ages of 18-80 who have been diagnosed with Irritable Bowel Syndrome (IBS) or who have had a history of abdominal pain, abdominal cramping, nausea, vomiting, diarrhea or bloating without an identifiable cause. The study will identify the frequency of Eosinophilic gastrointestinal diseases and elevated tissue mast cells in patients with chronic GI symptoms.

The study will last approximately 2 months with 3 of visits to our office. Compensation is available for time and travel for those who qualify. Study related care is available to participants at no cost and health insurance is not required nor needed.

Qualifications

  • Between the ages of 18-80 years old
  • Have a 6-month history of abdominal pain, abdominal cramping, nausea, vomiting, diarrhea, or bloating without identifiable cause or unresponsive to any drugs or dietary intervention or patients diagnosed with IBS
  • Please note, other conditions may apply.